Does Paxlovid reduce long COVID symptoms? Yale-led trial finds out Dr. Kamal Kant Kohli8 April 2025 9:00 PM ISTAntiviral medications nirmatrelvir/ritonavir (Paxlovid) were not effective in relieving long COVID symptoms, according to a new study published in The...
Extended Paxlovid may help some people with long COVID, finds study Dr. Kamal Kant Kohli8 Jan 2025 9:00 AM ISTAn up-close look at how patients respond to the drug at different times and doses adds nuance to a recent finding that Paxlovid does not work for long...
15-day Paxlovid regimen safe but adds no clear benefit for long-COVID patients: Stanford Medicine trial Dr. Kamal Kant Kohli10 Jun 2024 9:45 AM ISTIn a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid-an antiviral drug combination...
Increased use of Paxlovid could cut hospitalizations, deaths and costs Dr. Kamal Kant Kohli24 Feb 2024 6:00 AM ISTIncreased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of...
Former Pfizer employee convicted of insider trading on COVID drug Paxlovid trial Ruchika Sharma22 Jan 2024 10:11 AM ISTA former employee of Pfizer Inc was convicted of insider trading on Thursday for buying stock options in November 2021 just before Pfizer announced...
Paxlovid treatment fails to prevent long COVID in vaccinated, nonhospitalized individuals Dr. Kamal Kant Kohli11 Jan 2024 2:00 AM ISTUSA: A recent study published in the Journal of Medical Virology has revealed the ineffectiveness of Paxlovid (Nirmatrelvir-ritonavir) in reducing the...
Paxlovid does not reduce risk of long COVID: Study Roshni Dhar9 Jan 2024 5:52 PM ISTIn a recent study published in the Journal of Medical Virology, researchers from the University of California–San Francisco found that Paxlovid, the...
Health Bulletin 9/January/2024 Roshni Dhar9 Jan 2024 4:50 PM ISTHere are the top health stories of the day:NBE official website suspended amid uncertainty over NEET PG 2024 exam dateAmid the uncertainty regarding...
Pfizer slashes full-year revenue forecast by 13 percent on lower COVID sales Ruchika Sharma15 Oct 2023 11:30 AM ISTNew York: Pfizer has slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to...
Pfizer considers cost cuts as demand for COVID products falls Ruchika Sharma2 Aug 2023 3:30 PM ISTIf COVID vaccinations are very low this year, the company will scale back its investments for the virus, including combination shots, as part of its...
FDA Approves Paxlovid as first Oral Antiviral for Treating COVID-19 in Adults Dr. Kamal Kant Kohli29 May 2023 11:00 AM ISTThe U.S. Food and Drug Administration has approved first Oral Antiviral for Treating COVID-19 in Adults.Paxlovid is the fourth drug-and first oral...
USFDA nod to Pfizer Paxlovid for adult patients at high risk of progression to severe COVID 19 Ruchika Sharma26 May 2023 1:30 PM ISTPAXLOVID is a SARS-CoV-2 main protease (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease inhibitor) therapy.
